CELL AND GENE THERAPY INSIGHTS

August 2022 Issue

Volume 8 Issue 7

Cell and Gene Therapy Insights Volume 8 Issue 7
Download PDF

Featuring

Issue Spotlight: New horizons in cellular immunotherapy
Vectors focus: Upstream Bioprocessing 2022
Other articles

SPOTLIGHT

New horizons in cellular immunotherapy

Interview

Advancing genome edited allogeneic cell therapies into the clinic

Advancing genome edited allogeneic cell therapies into the clinic

Steve Kanner
26 August 2022
Read
Ensuring commercial readiness in the cellular cancer immunotherapy space

Ensuring commercial readiness in the cellular cancer immunotherapy space

Julian Adams, Michele Korfin, Ronit Simantov
16 August 2022
Read

Podcast

Working together to safely advance cell & gene therapies

Working together to safely advance cell & gene therapies

J Maher, A J King, F Neethling et al.
12 September 2022
Listen

Expert Roundtable

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Rupa Pike, Delara Motlagh, Patrick Hanley
5 October 2022
Read

FastFacts

Scalable production of lipid nanoparticles for effective gene delivery

Scalable production of lipid nanoparticles for effective gene delivery

Reka Geczy
12 October 2022
Read

Viewpoint

In vivo engineering of CAR T cell therapies

In vivo engineering of CAR T cell therapies

Haig Aghajanian
30 August 2022
Read
A journey in synthetic biology: using gene circuit technology in immuno-oncology

A journey in synthetic biology: using gene circuit technology in immuno-oncology

Timothy Lu, James Collins
25 August 2022
Read
The power of combining iPSC-derived NK cell therapy & NK-cell engager antibodies

The power of combining iPSC-derived NK cell therapy & NK-cell engager antibodies

Dr Wei Li, Dr Daniel Teper
22 July 2022
Read

Vectors FOCUS

Upstream Bioprocessing 2022

Innovator Insight

Complete system for AAV production for clinical production: part 1 – upstream

Complete system for AAV production for clinical production: part 1 – upstream

Jonathan Zmuda, Jenny England
26 October 2022
Read
Why Pall’s Allegro™ Stirred-Tank Bioreactor is ideal for viral vector cell culture

Why Pall’s Allegro™ Stirred-Tank Bioreactor is ideal for viral vector cell culture

E Cameau, E Asilonu, S Bah et al.
28 August 2022
Read

Interview

Driving significant AAV process yield and quality improvements for systemic delivery

Driving significant AAV process yield and quality improvements for systemic delivery

Rahul Chelikani
29 August 2022
Read

Podcast

Achieving better AAV vector productivity and product quality

Achieving better AAV vector productivity and product quality

Diane Golebiowski, Marissa Stanvick
22 July 2022
Listen

FastFacts

Leveraging a scalable, standardized platform process for suspension-based AAV and LV vector manufacture to accelerate time to clinic

Leveraging a scalable, standardized platform process for suspension-based AAV and LV vector manufacture to accelerate time to clinic

Samira Shore
29 July 2022
Read

Journal articles

Innovator Insight

Possibilities for continuous closed-system processing of cell therapies

Possibilities for continuous closed-system processing of cell therapies

S Werner, S Thompson, R Day et al.
17 August 2022
Read
Simplifying residual DNA analysis in viral vector production: focus on E1A

Simplifying residual DNA analysis in viral vector production: focus on E1A

12 August 2022
Read

Podcast

Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space

Accelerating cures: funding stem cell innovation & ideas in an evolving cell therapy space

Amritha Jaishankar
28 August 2022
Listen

Conference Insight

Achieve commercial success: the value of a sound manufacturing strategy

Achieve commercial success: the value of a sound manufacturing strategy

12 August 2022
Read

FastFacts

Tips and tricks for transfection, adaptation, and scale-up for AAV production

Tips and tricks for transfection, adaptation, and scale-up for AAV production

Amanda Zunic
28 August 2022
Read
POROSTM CaptureSelectTM AAVX elution optimization study for optimized recovery of AAV6 capsids

POROSTM CaptureSelectTM AAVX elution optimization study for optimized recovery of AAV6 capsids

Jenny England
27 August 2022
Read

Viewpoint

Lessons in scientific endeavor and innovation

Lessons in scientific endeavor and innovation

Irving Weissman
4 September 2022
Read

Poster

How can we maximize the efficiency of large-scale LV vector production?

How can we maximize the efficiency of large-scale LV vector production?

4 August 2022
Read
Scalable solutions for cell isolation and expansion

Scalable solutions for cell isolation and expansion

Evan Zynda
18 July 2022
Read